Dear colleagues!
On August 28, 2026, the full texts of the new clinical guidelines were published on the official website of the European Society of Cardiology (ESC), dedicated to the issues of cardiovascular diseases and chronic kidney disease.
The provisions of these clinical recommendations were presented to the participants of a number of specially organized scientific sessions, and also served as a reason for active discussions.

The report of Professor Mamedov M.N. was presented at the plenary session
Chinese National Congress on Hypertension
The Chinese National Congress on Hypertension was held in Zhengzhou from October 30 to November 1, 2026.
Largest medical organizations are calling for the prevention of cardiovascular diseases in girls in childhood
Four leading US medical organizations have developed a common concept for the prevention of cardiovascular diseases in women. The three-part guidance, published in Circulation, brings together the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine. It includes clinical guidance organized around women’s life stages, a scientific advisory explaining the framework, and a proposal for Comprehensive Centers of Excellence for Women’s Cardiovascular Care.
The new International Guidelines On Hypertension Recommend Two Main Treatment Groups
New global guidelines for hypertension recommend using two layers of treatment to account for areas around the world working with fewer resources. The International Society of Hypertension (ISH) guidelines, last updated in 2020, are organized around the concept of “essential” and “optimal” levels of care.
Europe Builds a Network to Bring AI Into Heart Care
The European Cardiovascular Health Data and AI Network (CHAIN), supported by the European Society of Cardiology, aims to harness health data and AI to improve cardiovascular care. In this context, a new initiative funded through EU4Health — the EU’s 2021-2027 program supporting health systems and health-related projects — aims to harness health data and AI across the cardiovascular care pathway.
Scotland Accepts New RNAi Therapy for Cardiac Amyloidosis
The Scottish Medicines Consortium (SMC) has accepted vutrisiran sodium (Amvuttra, Alnylam UK Ltd) for restricted use in NHS Scotland as monotherapy in adults with wild-type or hereditary transthyretin amyloidosis with cardiomyopathy (ATTR-CM).
European experts have proposed new criteria for the diagnosis of cardiogenic shock
The European Society of Cardiology has presented new criteria for the diagnosis of cardiogenic shock, which should help to identify the condition faster and unify approaches to its diagnosis. Experts suggest assessing at the same time the signs of impaired blood supply to organs, hemodynamic disorders and severe cardiac dysfunction.
Heart Failure Rewritten: What the 2026 ESC Guidelines Mean for Primary Care
At the 2026 Congress of the European Society of Cardiology (ESC), updates to the guidelines on heart failure (HF) were presented.
A new global definition of myocardial infarction
A new global definition of myocardial infarction has been devised by a task force of four major cardiology societies, with the goal of enabling cardiologists and other healthcare professionals to better diagnose and treat patients with the condition.
Most important clinical trials presented at the HOT LINE sessions of the European Society of Cardiology Congress 2026
The next Congress of the European Society of Cardiology was held in Munich (Germany) from August 28 to 31, 2026. The motto of this year's event is "Research. Innovation. Inspiration." The Congress participants reviewed 4 new texts of clinical recommendations in various fields of cardiology and other fields of medicine.
ACC and AHA updated their recommendations on statins in 2026
Cardiologists have revised the 2018 statin recommendations. After just under 10 years, during which the target indicators were based solely on percentage reduction, clear numerical target levels for low‑density lipoproteins have been re‑established.
New Tool to Guide Transcatheter Aortic Valve Replacement
A new German trigger tool identified adverse events in pediatric cardiology admissions, with most events causing temporary harm. The tool demonstrated good interrater reliability and was feasible for systematic detection of patient harm in hospitalized children.